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Schiff bases are versatile organic compounds, gaining importance day by day due to their wide applications. Schiff bases, 
containing imines or azomethine functional groups, are prepared by condensation of primary amines with carbonyl 
compounds or they may occur naturally in plants. They have lots of importance in industry and show numerous biological 
activities including antibacterial, antifungal, antiviral, anticancer, etc. The wide range of biological studies of the Schiff 
bases are now attracting the attention of researchers which can lead to the identification of promising lead compounds. This 
review consists of the recent developments and various methodologies to synthesize Schiff base as well as their biological 
activities covering the last 20 years. 
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Schiff Base (SB), a versatile compound discovered by 
chemist Hugo Schiff, is formed when condensation of 
primary amines with carbonyl compounds under 
specific reaction conditions
1
. They are also termed as 
imine or azomethine (-C=N-). SB ligands form more 
readily with aldehydes than ketones. Study on SB has 
been done due to its very flexible character and 
different structures. SBs form stable complexes with 
metal ions2-3. At very high temperature and in the 
presence of moisture many SBs show catalytic 
activity in various reactions. SB acts as an important 
intermediate in many enzymatic reactions which 
involves the interaction of an enzyme with carbonyl 
or an amino group of the substrate4-5. In the field of 
organic chemistry, SB shows large number of 
synthetic uses. It is widely used in organic compounds 
such as pigment, dyes, catalysts, intermediates and 
polymer stabilizers6. 
Imines group can be found in a variety of natural 
and synthetic compounds which show diverse 
biological activities. SB also shows several biological 
properties including anti-inflammatory, antimalarial, 
antifungal, antibacterial, antiviral, anti-proliferative 
and antipyretic, etc.7-36 SBs were showed antibacterial 
activity against some bacterial strains like Acinetobacter 
baumannii, Bacillus subtilis, Enterococcus faecalis, 
Escherichia coli, Klebsiella Pneumonia, M. tuberculosis, 
Micrococcus luteus, Micrococcus flavus, 
Mycobacterium phlei, Pseudomonas fluorescence, 
Proteus vulgaris, Salmonella  enteric, Staphylococcus 
aureus, Streptococcus epidermidis and S. pyogenes, 
etc.14-20 SBs were reported to exhibit antifungal 
activity against fungal strains including Aspergillus 
fumigatus, Aspergillus flavus, Aspergillus niger, 
Candida albicans, Candida tropicalis, Candida 
guilliermondii, Candida glabrata, Cryptococcus 
neoformans, Epidermophyton floccosum, Histoplasma 
capsulatum, Microsporum audouinii, Microsporum 
gypseum, Penicillium marneffei, Trichophyton 
mentagrophytes and Trichophyton rubrum, etc.21-24 
In our review, we describe the various reported 
schemes to the synthesized of SBs. We also highlight the 
biological activities of SBs reported in the literature. 
Synthesis of Schiff Bases 
Imine was prepared for the first time by Schiff in 
19th century. He reported the synthesis of imines 
under azeotropic distillation. Dehydrating agents such 
as molecular sieves or magnesium sulphate are used 
to remove water from the system (Figure 1). Later, 
numerous methods have been reported for the 
Figure 1 — General pathway for synthesis of a Schiff base




synthesis of imines. According to Chakraborti 
et al. 2004, the carbonyl compounds should be  
highly electrophilic and amines should be strongly 
nucleophilic for efficiency of the methods for 
synthesis of SB. A SB is formed when an aldehyde or 
ketone react with an amine by acid or base catalysis, 
or upon heating with the removal of water. Due to the 
presence of effective conjugation, aromatic aldehydes 
form stable SBs in comparison to aliphatic aldehydes. 
Various techniques including microwave irradiation38–
41, water suspension medium, solid-state synthesis, 
infrared irradiation and ultrasonication42-46 have been 
reported. The different schemes of synthesis of SBs 
are listed in Table I. 
 
Table I — The various Schiff bases 
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Hot ethanol; 












at 1:1 molar ratio; 
Ethanol (25 mL); 
Reflux (2 h) 
 
 




























at 1:1 molar ratio; 
Absolute Ethanol; 
Stirring 2h and (5-
10 h); 60-70°C; 
NaOH 
 
6 examples (51-85%) 
The preparation of 
SBs have been 
carried out by 
stirring at 60-70°C. 
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Table I — The various Schiff bases (Contd.) 















10 examples (60-75%) 
The SBs 
preparation have 






reaction took 5-6h, 
whereas by 
microwave 











Reflux; 8 h. 
 
2 examples (60-75%) 
The SBs were 








Amine at 1:1 
molar ratio; 
Water; 1-2 h 
b) Aldehyde: 
Amine at 1:1 
molar ratio; 
Microwave/ 50-
80°C; 30 sec to 2 
min. 
 
5 examples (90-96%) 
The SBs 
preparation have 




microwave, the best 







at 1:1 molar ratio; 
Reflux 1h; 
Ethanol; 
Pouring in ice 
 
1 example (60%) 
The condensation 
of SB was 
performed in reflux 


















11 examples (42-75%) 
SBs showed 
antimicrobial 
activity against six 










at 1:1 molar ratio; 
Reflux 2-3 h; 
Ethanol 
 
4 examples (76-87%) 
The condensation 
of o-hydroxyl 




carboxylate in 1:1 
molar ratio to form 
SB. 
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Table I — The various Schiff bases (Contd.) 




at 1:1 molar ratio; 
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performed in 
reflux condition 
































at 1:1 molar ratio; 
NaSO4, CHCl3; 
Reflux 24 h 
1 
example 
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performed in 













at 1:1 molar ratio; 
CH3COOH; 
Stirred. 
1.15- 2.00 h 
 
2 examples 
The SBs are 
yellow coloured 
solid with sharp 
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The SBs are 
yellow coloured 
solid with sharp 









































at 1:1 molar ratio; 
THF; Acetic acid 
(pH = 4-5); reflux 
24 h.  
4 examples (56-78%) 
SBs were reported 
as two pairs, one 
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Table I — The various Schiff bases (Contd.) 





at 1:1 molar ratio; 
Reflux 
 






than bromine and 
chlorine 







at 1:2 molar ratio; 
Reflux (4 h) 
Absolute EtOH 
 











at 1:1 molar ratio; 
Reflux (4 h) 
Dil HCl, 
CH3OH/Na  
10 examples (43-91%) 
 














at 1:1 molar ratio; 
2% acetic acid; 
RT (6 h); 10 mL 
EtOH 
 
1 example (91%) 
Five different 
molar ratios of 
Chitosan-
Cinnamaldehyde 
were prepared. It 
was found that 
increasing the 
cinnamaldehyde 
ratio to chitosan 
increases the 





at 1:1 molar ratio; 
Reflux (7 h) 
warm ethanol (20 
mL); glacial 
acetic acid in 
EtOH 
 
12 examples (70-99%) 
Twelve new bis-
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Table I — The various Schiff bases (Contd.) 





at 1:1 molar ratio; 






activity against the 
tested Gram 







at 1:1 molar ratio; 
water bath (8h); 
Ethanol   
1 example 
 
SB is found active 




Biological activities of Schiff bases 
 
Antibacterial activity 
SBs have been reported to exhibit as significant 
antibacterial agents2. There are several synthetic or 
plant produced Schiff bases possess antibacterial 
activity. Shi et al., 2007 studied antimicrobial activity 
of synthesized 5-chlorosalicylaldehyde Shiff base 
derivatives (1-10) against P. fluorescence, E. coli,  
B. subtilis and S. aureus. Compounds (1-10) were found 
most active against P. fluorescence with MIC values 
2.5-5.2 µg/mL, whereas reference drug kanamycin 
showed MIC value 3.9 µg/mL. The Schiff bases 1, 2, 
4–6 and 9-10 showed antibacterial activity against  
E. coli with MIC value 1.6–5.7 µg/mL. Compound 9 
showed antibacterial activity against B. subtilis (MIC 
value 1.8 µg/mL) whereas compounds 1 and 2 
exhibited  activity against S. aureus with MIC values 
3.1 and 1.6 µg/mL respectively14. Pandeya et al., 
1999a, 1999b reported antibacterial activity of  
Isatin-derived Schiff base 11 against twenty-eight 
pathogenic bacteria compared with sulfamethoxazole 
as reference drug. According to Hearn et al., 2004  
the isoniazid-derived Schiff base 12 exhibited 
antibacterial activity against M. tuberculosis H37Rv 
with MIC value of 0.03 mg/L. Panneerselvam et al., 
2005 tested antibacterial activity of morpholine-
derived Schiff bases (13–15) against S. aureus,  
M. luteus, S. epidermidis, B. cereus and E. coli. They 
reported that compound 13 showed activity S. aureus, 
M. luteus with MIC values 20 and 32 µg/mL, 
respectively. Compound 14 exhibited activity against 
S. epidermidis with MIC value 17 µg/mL. Moreover, 
compound 15 reported inhibition against B. cereus 
and E. coli with MIC values 21 and 16 µg/mL, 
respectively. According to Karthikeyan et al., 2006, 
Schiff bases with a 2,4-dichloro-5-fluorophenyl 
compounds (16–19) were reported to hinder  
the bacterial growth against S. aureus, E. coli,  
P. aeruginosa, and K. pneumonia with MIC values 
from 6.3 to 12.5 µg/mL, compared with reference 
drug Ciprofloxacin. The compounds are depicted in 
Figure 2. 
The dimeric disulphide Schiff base derivatives  
20-22 were studied for antimicrobial activity against 
A. baumannii, E. coli, K. pneumaniae, S. aureus,  
C. tropicalis, C. guilliermondii, C. albicans and  
C. glabrata by Disc diffusion method compared with 
standard Cefotaxime, Amoxicillin/clavulanic acid for 
antibacterial and Posaconazole for antifungal. SB (20) 
exhibited more inhibition against bacteria as 
compared to other SBs in which K. pneumaniae is the 
most sensitive bacterium. The fluorine containing SBs 
exhibited higher antimicrobial activity than bromine 
and chlorine containing SBs20. SBs (23-27) were 
studied for antimicrobial activity against pathogenic 
microorganisms by disc diffusion method with test 
sample 250 µg/disc. The results showed zones of 
inhibition for the SBs ranged from 0.9 to 3 cm for 
Gram positive bacteria, from 0.7 to 2.5 cm for gram-
negative bacteria and from 0.6 to 2.4 cm for Candida 
which indicate better effect against gram positive 
bacteria than against gram negative and Candida21.  
A novel series of SBs 2-amino-4-(o-chloroanilino)-
1,3-thiazole (28-37) exhibited promising antibacterial 
activity against S. aureus, B. subtilis, E. coli and  
K. pneumaniae. Cinnamyl chitosan SB was (38) showed 
to have antimicrobial activity against S. aureus, 
S. pyogenes, P. aeruginosa, P. vulgaris and Shigella. 
Salihovic et al., 2018 studied the in vitro 
antimicrobial activity of SBs (39-41) against bacteria 
S. aureus, Methicillin-resistant S. aureus: MRSA,  
B. subtilis, E. faecalis, S. enteric, P. aeruginosa,  
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E. coli, and one yeast C. albicans by Agar Well
Diffusion Method. SB (39) showed maximum
inhibition against the microorganisms.
Madura hydroxylactone SBs (42–47) (Figure 3) 
isolated from Actinomadura rubra inhibited bacterial 
growth of B. subtilis, M. flavus, Sa. lutea, and 
S. aureus, with MIC values 0.2-3.1 µg/mL. They also
showed very low activity against M. phlei or
P. vulgaris with MIC value 50.0 µg/mL23-24.
Antifungal activity 
Both synthetic and naturally occurring Schiff bases 
reported promising antifungal activity (Figure 4). 2,4-
dichloro-5-fluorophenyl Schiff bases (16, 48–51) 
inhibit the growth of fungi against Aspergillus 
fumigatus, Aspergillus flavus, Penicillium marneffei, 
and Trichophyton mentagrophytes with MIC values 
range of 6.3–12.5 µg/mL, compared with reference 
fluconazole19. 
According to Echevarria et al., 1999, Piperonyl-
derived Schiff bases (52–57) repressed the growth of 
fungi Trichophyton rubrum and Epidermophyton 
floccosum with MIC values 820–980 µM and 
200–930 µM, respectively. The isatin-derived Schiff 
bases (11, 58–68) were found to have antifungal 
activity against Microsporuma udouinii and 
Microsporum gypseum with MIC values ranging from 
2.4-9.7 µg/mL and 1.2-9.7 µg/mL, repectively15. 
Further, compounds (11, 58–68) also showed 
inhibition against Aspergillus niger, Candida 
albicans, Cryptococcus neoformans, E. floccosum, 
Histoplasma   capsulatum  and  T.  mentagrophytes  at 
Figure 2 — Structures of synthetic antibacterial Schiff bases 
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MIC values 10-79 µg/mL16. Compounds 14 and 69 
exhibited antifungal activity against C. albicans and 
A. niger conceded by  treatment  at  20 and 30 µg/mL,
repectively. Compound 70, a natural product derived
Schiff base reported antifungal activity against
C. albicans and C. neoformans at 20 µg/mL, whereas
for free nystatin required a concentration of 10 µg/mL.
SB (25) showed moderate activity against Candida
(24 µg/mL) and could be a promising anti microbial
agent21. The SBs 2-amino-4-(o-chloroanilino)-1,3-
thiazole (28-37) exhibited promising antifungal
activity against C. albicans and A. niger26. The
hydrazone SB (71) synthesized by Pawaiya et al.,
2014 exhibited antifungal activity against C. albicans,
A. niger, and Penicillium sp.
Figure 3 — Structures of some antibacterial Schiff bases derived 
from plant 
Figure 4 — Structures of some antifungal Schiff bases
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Antimalarial activity 
A series of fifteen SBs derived from aromatic 
sulphonamides were tested as inhibitors of 
Plasmodium falciparum carbonic anhydrase enzyme 
compared with clinical drug acetazolamide (Figure 5). 
SBs 72-77 inhibited parasite activity with an affinity 
constant (KI) ranging from 0.54-1.23 µg/mL against 
carbonic anhydrase enzyme27-28. SBs 78-80 exhibited 
good antimalarial activity against the tested 
3D7 strain with IC50 values ranging from 19.69 to 
25.38 µg/mL. SBs 81-86 exhibited antimalarial 
activity inhibiting the growth of this parasite 
(IC50, 2.28 - 26.9 µg/mL
29.
Antiviral activity 
A 1-amino-3-hydroxyguanidine tosylate derived 
SB (87) was reported to exhibit antiviral activity 
against mouse hepatitis virus (MHV), by 50% 
inhibition in growth at concentrations of 3.2 µM30 
(Figure 6). Further, according to Sriram et al., 2006 
Figure 5 — Structures of some antimalarial Schiff bases 
Figure 6 — Structures of some antiviral Schiff bases
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the abacavir-derived Schiff bases (88–98) showed 
significant antiviral activity against HIV-1 in which 
compound 90 was the most potent Schiff base, being 
effective at 50 nM, could be a principal compound for 
new anti-HIV-1 (Figure 6). The new bis-Schiff bases 
of isatin, benzylisatin and 5-fluoroisatin (99-110) 
were reported having antiviral activity in human 
embryonic lung (HEL) and human epithelial (HeLa) 
cells and African green monkey kidney (Vero) cells31.  
Antioxidant activity 
The SB (111) bearing N,N-dimethylamino 
benzaldehyde and 4-hydroxy benzaldehyde showed 
antioxidant activity with IC50 value 50 mM compared 
with curcumin using 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) assay32 (Figure 7). Vreese et al., 2016 studied 
antioxidant activity of thirteen new derivatives 
(112-124) bearing a β-enaminone by DPPH and the 
ferric reducing ability of plasma (FRAP) assays. 
SBs showed antioxidant activity by both tests 
(0.08–0.13% inhibition per mM by DPPH assay and 
0.83–1.29 Trolox equiv. per mM by FRAP assay) 
compared with curcumin (0.15% inhibition per mM 
by DPPH assay and 1 Trolox equiv. per mM by 
FRAP assay)33-34. The new enaminone analogues 
(125-132) exhibited antioxidant activities comparable 
to curcumin35-36. 
Conclusion 
This article summarizes the working procedures of 
preparation of Schiff base since they have many 
important applications in organic chemistry. In this 
article we have also highlighted various biological 
activities of Schiff base. 
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